1. Home
  2. BXP vs ALGN Comparison

BXP vs ALGN Comparison

Compare BXP & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BXP
  • ALGN
  • Stock Information
  • Founded
  • BXP 1970
  • ALGN 1997
  • Country
  • BXP United States
  • ALGN United States
  • Employees
  • BXP N/A
  • ALGN N/A
  • Industry
  • BXP Real Estate Investment Trusts
  • ALGN Industrial Specialties
  • Sector
  • BXP Real Estate
  • ALGN Health Care
  • Exchange
  • BXP Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • BXP 11.8B
  • ALGN 9.5B
  • IPO Year
  • BXP 1997
  • ALGN N/A
  • Fundamental
  • Price
  • BXP $73.00
  • ALGN $133.04
  • Analyst Decision
  • BXP Hold
  • ALGN Buy
  • Analyst Count
  • BXP 16
  • ALGN 13
  • Target Price
  • BXP $77.00
  • ALGN $212.92
  • AVG Volume (30 Days)
  • BXP 2.2M
  • ALGN 1.2M
  • Earning Date
  • BXP 10-28-2025
  • ALGN 10-29-2025
  • Dividend Yield
  • BXP 5.37%
  • ALGN N/A
  • EPS Growth
  • BXP N/A
  • ALGN 0.42
  • EPS
  • BXP 0.03
  • ALGN 5.92
  • Revenue
  • BXP $3,410,208,000.00
  • ALGN $3,964,802,000.00
  • Revenue This Year
  • BXP $2.65
  • ALGN $2.08
  • Revenue Next Year
  • BXP $2.42
  • ALGN $3.33
  • P/E Ratio
  • BXP $2,622.50
  • ALGN $22.48
  • Revenue Growth
  • BXP 2.91
  • ALGN 0.56
  • 52 Week Low
  • BXP $54.22
  • ALGN $122.00
  • 52 Week High
  • BXP $90.11
  • ALGN $246.19
  • Technical
  • Relative Strength Index (RSI)
  • BXP 47.23
  • ALGN 45.45
  • Support Level
  • BXP $73.02
  • ALGN $123.02
  • Resistance Level
  • BXP $75.66
  • ALGN $134.98
  • Average True Range (ATR)
  • BXP 1.52
  • ALGN 3.02
  • MACD
  • BXP -0.56
  • ALGN 1.25
  • Stochastic Oscillator
  • BXP 5.18
  • ALGN 66.62

About BXP Boston Properties Inc.

BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: